| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Nov 20, 2025 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 30.0 | -10,000 | -6.71% | ✓ | $250K |
| Sep 7, 2025 | Sep 9, 2025 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 48.8 | -871 | -0.58% | ✗ | $16.6K |
| Aug 11, 2025 | Aug 13, 2025 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 22.5 | -10,000 | -6.32% | ✗ | $176.9K |
| Jul 28, 2025 | Jul 30, 2025 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 42.5 | -5,149 | -3.15% | ✗ | $98.6K |
| Jun 8, 2025 | Jun 11, 2025 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 46.3 | -5,162 | -3.26% | ✗ | $38K |
| Jan 31, 2025 | Feb 4, 2025 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 42.5 | -4,551 | -1.02% | ✗ | $50.7K |
| Sep 9, 2024 | Sep 12, 2024 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 48.8 | -859 | -0.59% | ✗ | $11.2K |
| Jun 10, 2024 | Jun 11, 2024 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 42.5 | -5,153 | -3.45% | ✗ | $67.4K |
| Mar 18, 2024 | Mar 20, 2024 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 22.5 | -12,000 | -7.92% | ✗ | $168.6K |
| Feb 1, 2024 | Feb 5, 2024 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 32.5 | -3,789 | -0.83% | ✗ | $59.8K |
| Jan 31, 2024 | Feb 2, 2024 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 45.0 | -3,789 | -0.83% | ✗ | $59.6K |
| Jan 31, 2023 | Feb 2, 2023 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 51.3 | -1,900 | -0.43% | ✗ | $19.2K |
| Oct 31, 2022 | Nov 2, 2022 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 47.5 | -258 | -1.07% | ✗ | $3.1K |
| Jul 31, 2022 | Aug 25, 2022 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 47.5 | -259 | -1.08% | ✗ | $2K |
| Apr 30, 2022 | May 3, 2022 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 47.5 | -254 | -1.07% | ✗ | $1.7K |
| Jan 31, 2022 | Feb 2, 2022 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 46.3 | -1,374 | -2.93% | ✗ | $10.4K |
| Jan 26, 2022 | Jan 28, 2022 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 52.5 | -111 | -0.50% | ✗ | $898 |
| Nov 18, 2021 | Nov 19, 2021 | UroGen Pharma Ltd. | Chief Medical Officer | Buy | 67.5 | +160 | 0.73% | ✗ | $2.1K |
| Oct 31, 2021 | Nov 2, 2021 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 47.5 | -258 | -1.17% | ✗ | $4.4K |
| Oct 26, 2021 | Oct 28, 2021 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 52.5 | -107 | -0.49% | ✗ | $1.7K |
| Jul 31, 2021 | Aug 3, 2021 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 47.5 | -243 | -1.12% | ✗ | $3.8K |
| Jul 26, 2021 | Jul 28, 2021 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 52.5 | -103 | -0.49% | ✗ | $1.6K |
| Apr 30, 2021 | May 4, 2021 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 47.5 | -243 | -1.14% | ✗ | $4.9K |
| Apr 26, 2021 | Apr 27, 2021 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 52.5 | -89 | -0.42% | ✗ | $1.7K |
| Jan 31, 2021 | Feb 2, 2021 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 46.3 | -1,076 | -4.93% | ✗ | $23.7K |
| Jan 26, 2021 | Jan 26, 2021 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 50.0 | -100 | -0.50% | ✗ | $2.2K |
| Dec 4, 2020 | Dec 7, 2020 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 46.3 | -662 | -3.25% | ✗ | $13.1K |
| Oct 26, 2020 | Oct 28, 2020 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 50.0 | -101 | -0.52% | ✗ | $2.1K |
| Sep 4, 2020 | Sep 8, 2020 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 47.5 | -348 | -1.78% | ✗ | $7K |
| Jul 26, 2020 | Jul 28, 2020 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 52.5 | -70 | -0.38% | ✗ | $1.6K |
| Jun 4, 2020 | Jun 5, 2020 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 47.5 | -349 | -1.86% | ✗ | $9.6K |
| Apr 26, 2020 | Apr 28, 2020 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 52.5 | -70 | -0.39% | ✗ | $1.7K |
| Mar 4, 2020 | Mar 4, 2020 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 46.3 | -345 | -1.93% | ✗ | $10.2K |
| Jan 26, 2020 | Jan 28, 2020 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 47.5 | -322 | -3.39% | ✗ | $9.4K |
| Dec 4, 2019 | Dec 5, 2019 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 46.3 | -343 | -3.81% | ✗ | $10.9K |
| Nov 19, 2019 | Nov 21, 2019 | UroGen Pharma Ltd. | Chief Medical Officer | Buy | 95.0 | +1,960 | 32.63% | ✗ | $55.2K |
| Sep 4, 2019 | Sep 6, 2019 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 46.3 | -343 | -5.40% | ✗ | $11.6K |
| Jun 4, 2019 | Jun 6, 2019 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 46.3 | -343 | -6.07% | ✗ | $12K |
| Mar 21, 2019 | Mar 22, 2019 | UroGen Pharma Ltd. | Chief Medical Officer | Buy | 86.3 | +272 | 6.27% | ✗ | $10.1K |
| Mar 4, 2019 | Mar 7, 2019 | UroGen Pharma Ltd. | Chief Medical Officer | Sell | 42.5 | -1,991 | -31.46% | ✗ | $74.3K |